Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc.verified

SRPT

Price:

$124.25

Market Cap:

$11.85B

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; and VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping. The company is also developing AMONDYS 45, a product candidate that uses phosphorodiamidate morpholino oligomer chemistry and exon-skipping tech...[Read more]

Industry

Biotechnology

IPO Date

1997-06-04

Stock Exchange

NASDAQ

Ticker

SRPT

The ROE as of October 2024 (TTM) for Sarepta Therapeutics, Inc. (SRPT) is 5.17%

According to Sarepta Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 5.17%. This represents a change of 378.96% compared to the average of 1.08% of the last 4 quarters.

Sarepta Therapeutics, Inc. (SRPT) Historical ROE (quarterly & annually)

How has SRPT ROE performed in the past?

The mean historical ROE of Sarepta Therapeutics, Inc. over the last ten years is -74.17%. The current 5.17% ROE has changed -106.97% with respect to the historical average. Over the past ten years (40 quarters), SRPT's ROE was at its highest in in the March 2017 quarter at 19.59%. The ROE was at its lowest in in the March 2023 quarter at -72.50%.

Quarterly (TTM)
Annual

Average

-74.17%

Median

-67.56%

Minimum

-182.75%

Maximum

-6.42%

Sarepta Therapeutics, Inc. (SRPT) ROE by Quarter and Year

Discovering the peaks and valleys of Sarepta Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 445.89%

Maximum Annual ROE = -6.42%

Minimum Annual Increase = -91.91%

Minimum Annual ROE = -182.75%

Quarterly (TTM)
Annual
YearROEChange
2023-62.37%-65.87%
2022-182.75%304.97%
2021-45.13%-37.96%
2020-72.74%-16.77%
2019-87.40%149.28%
2018-35.06%445.89%
2017-6.42%-91.91%
2016-79.38%-31.33%
2015-115.59%110.82%
2014-54.83%21.03%

Sarepta Therapeutics, Inc. (SRPT) Average ROE

How has SRPT ROE performed in the past?

The current ROE of Sarepta Therapeutics, Inc. (SRPT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-96.75%

5-year avg

-90.08%

10-year avg

-74.17%

Sarepta Therapeutics, Inc. (SRPT) ROE vs. Peers

How is SRPT’s ROE compared to its peers?

Sarepta Therapeutics, Inc.’s ROE is less than Reata Pharmaceuticals, Inc. (19.32%), greater than Mirati Therapeutics, Inc. (-81.10%), less than Krystal Biotech, Inc. (13.36%), greater than Intercept Pharmaceuticals, Inc. (-78.24%), less than PTC Therapeutics, Inc. (57.03%), greater than Iovance Biotherapeutics, Inc. (-65.04%), greater than Madrigal Pharmaceuticals, Inc. (-95.61%), greater than Viking Therapeutics, Inc. (-15.05%), greater than Hepion Pharmaceuticals, Inc. (-328.66%), less than Terns Pharmaceuticals, Inc. (0%), greater than Akero Therapeutics, Inc. (-39.58%), greater than null (-29.56%),

Build a custom stock screener for Sarepta Therapeutics, Inc. (SRPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sarepta Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sarepta Therapeutics, Inc. (SRPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sarepta Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Sarepta Therapeutics, Inc.'s ROE?

How is the ROE calculated for Sarepta Therapeutics, Inc. (SRPT)?

What is the highest ROE for Sarepta Therapeutics, Inc. (SRPT)?

What is the 3-year average ROE for Sarepta Therapeutics, Inc. (SRPT)?

What is the 5-year average ROE for Sarepta Therapeutics, Inc. (SRPT)?

How does the current ROE for Sarepta Therapeutics, Inc. (SRPT) compare to its historical average?